Gut microbiome-derived metabolites modulate intestinal epithelial cell damage and mitigate graft-versus-host disease

Nathan D. Mathewson, Robert Jenq, Anna V. Mathew, Mark Koenigsknecht, Alan Hanash, Tomomi Toubai, Katherine Oravecz-Wilson, Shin Rong Wu, Yaping Sun, Corinne Rossi, Hideaki Fujiwara, Jaeman Byun, Yusuke Shono, Caroline Lindemans, Marco Calafiore, Thomas C. Schmidt, Kenya Honda, Vincent B. Young, Subramaniam Pennathur, Marcel Van Den BrinkPavan Reddy

Research output: Contribution to journalArticle

153 Citations (Scopus)

Abstract

The effect of alterations in intestinal microbiota on microbial metabolites and on disease processes such as graft-versus-host disease (GVHD) is not known. Here we carried out an unbiased analysis to identify previously unidentified alterations in gastrointestinal microbiota-derived short-chain fatty acids (SCFAs) after allogeneic bone marrow transplant (allo-BMT). Alterations in the amount of only one SCFA, butyrate, were observed only in the intestinal tissue. The reduced butyrate in CD326 + intestinal epithelial cells (IECs) after allo-BMT resulted in decreased histone acetylation, which was restored after local administration of exogenous butyrate. Butyrate restoration improved IEC junctional integrity, decreased apoptosis and mitigated GVHD. Furthermore, alteration of the indigenous microbiota with 17 rationally selected strains of high butyrate-producing Clostridia also decreased GVHD. These data demonstrate a heretofore unrecognized role of microbial metabolites and suggest that local and specific alteration of microbial metabolites has direct salutary effects on GVHD target tissues and can mitigate disease severity.

Original languageEnglish
Pages (from-to)505-513
Number of pages9
JournalNature Immunology
Volume17
Issue number5
DOIs
Publication statusPublished - 2016 May 1
Externally publishedYes

Fingerprint

Butyrates
Graft vs Host Disease
Epithelial Cells
Volatile Fatty Acids
Bone Marrow
Transplants
Clostridium
Microbiota
Acetylation
Histones
Gastrointestinal Microbiome
Apoptosis

ASJC Scopus subject areas

  • Immunology

Cite this

Mathewson, N. D., Jenq, R., Mathew, A. V., Koenigsknecht, M., Hanash, A., Toubai, T., ... Reddy, P. (2016). Gut microbiome-derived metabolites modulate intestinal epithelial cell damage and mitigate graft-versus-host disease. Nature Immunology, 17(5), 505-513. https://doi.org/10.1038/ni.3400

Gut microbiome-derived metabolites modulate intestinal epithelial cell damage and mitigate graft-versus-host disease. / Mathewson, Nathan D.; Jenq, Robert; Mathew, Anna V.; Koenigsknecht, Mark; Hanash, Alan; Toubai, Tomomi; Oravecz-Wilson, Katherine; Wu, Shin Rong; Sun, Yaping; Rossi, Corinne; Fujiwara, Hideaki; Byun, Jaeman; Shono, Yusuke; Lindemans, Caroline; Calafiore, Marco; Schmidt, Thomas C.; Honda, Kenya; Young, Vincent B.; Pennathur, Subramaniam; Van Den Brink, Marcel; Reddy, Pavan.

In: Nature Immunology, Vol. 17, No. 5, 01.05.2016, p. 505-513.

Research output: Contribution to journalArticle

Mathewson, ND, Jenq, R, Mathew, AV, Koenigsknecht, M, Hanash, A, Toubai, T, Oravecz-Wilson, K, Wu, SR, Sun, Y, Rossi, C, Fujiwara, H, Byun, J, Shono, Y, Lindemans, C, Calafiore, M, Schmidt, TC, Honda, K, Young, VB, Pennathur, S, Van Den Brink, M & Reddy, P 2016, 'Gut microbiome-derived metabolites modulate intestinal epithelial cell damage and mitigate graft-versus-host disease', Nature Immunology, vol. 17, no. 5, pp. 505-513. https://doi.org/10.1038/ni.3400
Mathewson, Nathan D. ; Jenq, Robert ; Mathew, Anna V. ; Koenigsknecht, Mark ; Hanash, Alan ; Toubai, Tomomi ; Oravecz-Wilson, Katherine ; Wu, Shin Rong ; Sun, Yaping ; Rossi, Corinne ; Fujiwara, Hideaki ; Byun, Jaeman ; Shono, Yusuke ; Lindemans, Caroline ; Calafiore, Marco ; Schmidt, Thomas C. ; Honda, Kenya ; Young, Vincent B. ; Pennathur, Subramaniam ; Van Den Brink, Marcel ; Reddy, Pavan. / Gut microbiome-derived metabolites modulate intestinal epithelial cell damage and mitigate graft-versus-host disease. In: Nature Immunology. 2016 ; Vol. 17, No. 5. pp. 505-513.
@article{a459cde439854c15a299d9560402250c,
title = "Gut microbiome-derived metabolites modulate intestinal epithelial cell damage and mitigate graft-versus-host disease",
abstract = "The effect of alterations in intestinal microbiota on microbial metabolites and on disease processes such as graft-versus-host disease (GVHD) is not known. Here we carried out an unbiased analysis to identify previously unidentified alterations in gastrointestinal microbiota-derived short-chain fatty acids (SCFAs) after allogeneic bone marrow transplant (allo-BMT). Alterations in the amount of only one SCFA, butyrate, were observed only in the intestinal tissue. The reduced butyrate in CD326 + intestinal epithelial cells (IECs) after allo-BMT resulted in decreased histone acetylation, which was restored after local administration of exogenous butyrate. Butyrate restoration improved IEC junctional integrity, decreased apoptosis and mitigated GVHD. Furthermore, alteration of the indigenous microbiota with 17 rationally selected strains of high butyrate-producing Clostridia also decreased GVHD. These data demonstrate a heretofore unrecognized role of microbial metabolites and suggest that local and specific alteration of microbial metabolites has direct salutary effects on GVHD target tissues and can mitigate disease severity.",
author = "Mathewson, {Nathan D.} and Robert Jenq and Mathew, {Anna V.} and Mark Koenigsknecht and Alan Hanash and Tomomi Toubai and Katherine Oravecz-Wilson and Wu, {Shin Rong} and Yaping Sun and Corinne Rossi and Hideaki Fujiwara and Jaeman Byun and Yusuke Shono and Caroline Lindemans and Marco Calafiore and Schmidt, {Thomas C.} and Kenya Honda and Young, {Vincent B.} and Subramaniam Pennathur and {Van Den Brink}, Marcel and Pavan Reddy",
year = "2016",
month = "5",
day = "1",
doi = "10.1038/ni.3400",
language = "English",
volume = "17",
pages = "505--513",
journal = "Nature Immunology",
issn = "1529-2908",
publisher = "Nature Publishing Group",
number = "5",

}

TY - JOUR

T1 - Gut microbiome-derived metabolites modulate intestinal epithelial cell damage and mitigate graft-versus-host disease

AU - Mathewson, Nathan D.

AU - Jenq, Robert

AU - Mathew, Anna V.

AU - Koenigsknecht, Mark

AU - Hanash, Alan

AU - Toubai, Tomomi

AU - Oravecz-Wilson, Katherine

AU - Wu, Shin Rong

AU - Sun, Yaping

AU - Rossi, Corinne

AU - Fujiwara, Hideaki

AU - Byun, Jaeman

AU - Shono, Yusuke

AU - Lindemans, Caroline

AU - Calafiore, Marco

AU - Schmidt, Thomas C.

AU - Honda, Kenya

AU - Young, Vincent B.

AU - Pennathur, Subramaniam

AU - Van Den Brink, Marcel

AU - Reddy, Pavan

PY - 2016/5/1

Y1 - 2016/5/1

N2 - The effect of alterations in intestinal microbiota on microbial metabolites and on disease processes such as graft-versus-host disease (GVHD) is not known. Here we carried out an unbiased analysis to identify previously unidentified alterations in gastrointestinal microbiota-derived short-chain fatty acids (SCFAs) after allogeneic bone marrow transplant (allo-BMT). Alterations in the amount of only one SCFA, butyrate, were observed only in the intestinal tissue. The reduced butyrate in CD326 + intestinal epithelial cells (IECs) after allo-BMT resulted in decreased histone acetylation, which was restored after local administration of exogenous butyrate. Butyrate restoration improved IEC junctional integrity, decreased apoptosis and mitigated GVHD. Furthermore, alteration of the indigenous microbiota with 17 rationally selected strains of high butyrate-producing Clostridia also decreased GVHD. These data demonstrate a heretofore unrecognized role of microbial metabolites and suggest that local and specific alteration of microbial metabolites has direct salutary effects on GVHD target tissues and can mitigate disease severity.

AB - The effect of alterations in intestinal microbiota on microbial metabolites and on disease processes such as graft-versus-host disease (GVHD) is not known. Here we carried out an unbiased analysis to identify previously unidentified alterations in gastrointestinal microbiota-derived short-chain fatty acids (SCFAs) after allogeneic bone marrow transplant (allo-BMT). Alterations in the amount of only one SCFA, butyrate, were observed only in the intestinal tissue. The reduced butyrate in CD326 + intestinal epithelial cells (IECs) after allo-BMT resulted in decreased histone acetylation, which was restored after local administration of exogenous butyrate. Butyrate restoration improved IEC junctional integrity, decreased apoptosis and mitigated GVHD. Furthermore, alteration of the indigenous microbiota with 17 rationally selected strains of high butyrate-producing Clostridia also decreased GVHD. These data demonstrate a heretofore unrecognized role of microbial metabolites and suggest that local and specific alteration of microbial metabolites has direct salutary effects on GVHD target tissues and can mitigate disease severity.

UR - http://www.scopus.com/inward/record.url?scp=84961392222&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84961392222&partnerID=8YFLogxK

U2 - 10.1038/ni.3400

DO - 10.1038/ni.3400

M3 - Article

C2 - 26998764

AN - SCOPUS:84961392222

VL - 17

SP - 505

EP - 513

JO - Nature Immunology

JF - Nature Immunology

SN - 1529-2908

IS - 5

ER -